What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
His primary areas of investigation include Immunology, Internal medicine, Acquired immunodeficiency syndrome, Cohort study and Viral load.
His Immunology research incorporates elements of Odds ratio, Incidence and Hazard ratio.
His Internal medicine research incorporates themes from Gastroenterology, Surgery and Ritonavir.
His studies in Acquired immunodeficiency syndrome integrate themes in fields like Viral disease, Pharmacotherapy and Epidemiology.
His Cohort study study combines topics in areas such as Prospective cohort study, Survival analysis, Pediatrics and Cohort.
Hansjakob Furrer combines subjects such as Developed country, Environmental health, Cellular immunity, Program evaluation and Antiretroviral therapy with his study of Viral load.
His most cited work include:
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (1019 citations)
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study (857 citations)
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. (804 citations)
What are the main themes of his work throughout his whole career to date?
Hansjakob Furrer mostly deals with Internal medicine, Immunology, Cohort study, Acquired immunodeficiency syndrome and Viral load.
His Internal medicine study frequently draws connections between adjacent fields such as Surgery.
His research in Immunology intersects with topics in Tuberculosis and Virology.
His study focuses on the intersection of Cohort study and fields such as Odds ratio with connections in the field of Logistic regression.
The study incorporates disciplines such as Pharmacotherapy and Risk factor in addition to Acquired immunodeficiency syndrome.
His study in Viral load is interdisciplinary in nature, drawing from both Gastroenterology and Regimen.
He most often published in these fields:
- Internal medicine (47.48%)
- Immunology (37.65%)
- Cohort study (32.37%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (47.48%)
- Cohort study (32.37%)
- Prospective cohort study (11.03%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cohort study, Prospective cohort study, Viral load and Odds ratio.
Within one scientific family, Hansjakob Furrer focuses on topics pertaining to Randomized controlled trial under Cohort study, and may sometimes address concerns connected to Emergency medicine, Linear model and Marginal structural model.
His work deals with themes such as Regimen, Acquired immunodeficiency syndrome, Coinfection, Seroconversion and Pediatrics, which intersect with Prospective cohort study.
His Viral load study necessitates a more in-depth grasp of Immunology.
Particularly relevant to T lymphocyte is his body of work in Immunology.
His Odds ratio research is multidisciplinary, incorporating elements of Overweight, Men who have sex with men and Quartile, Confidence interval.
Between 2016 and 2021, his most popular works were:
- Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (249 citations)
- Adverse events of raltegravir and dolutegravir (53 citations)
- Hepatitis Delta-Associated Mortality in HIV/HBV-coinfected Patients (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Hansjakob Furrer mainly focuses on Prospective cohort study, Internal medicine, Cohort study, Cohort and Pediatrics.
His Prospective cohort study research integrates issues from Acquired immunodeficiency syndrome, Viral load and Hazard ratio.
His Internal medicine study incorporates themes from Virological response, Surgery, Immunology and Hepatitis C virus.
Hansjakob Furrer interconnects Liver cancer and Hepatocellular carcinoma in the investigation of issues within Immunology.
His Cohort study study integrates concerns from other disciplines, such as Dolutegravir, Discontinuation and Confidence interval.
The Pediatrics study combines topics in areas such as Odds ratio, Relative risk, Randomized controlled trial, Reverse-transcriptase inhibitor and Drug resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
